Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US
Christina G. Wong(Cleveland Clinic), Zhengyang Zhou(Tianjin Medical University Cancer Institute and Hospital), Arthur W. Toga(University of California, Los Angeles), Robert A. Rissman(University of Southern California), Ganesh M. Babulal(Washington University in St. Louis), Robert Barber(University of North Texas), Ann D. Cohen(University of Pittsburgh), Mónica Rivera Mindt(Fordham University), Matthew Borzage(University of Southern California), Lisa L. Barnes(Rush University Medical Center), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Brad T. Christian, Stephanie Large, Rajesh Nandy, Kristine Yaffe(University of California, San Francisco), Raul Vintimilla, Sid E. O’Bryant(University of North Texas), Rema Raman(University of Southern California), David Mason, Beau M. Ances(Hospital of the University of Pennsylvania), Amy Kind(University of Wisconsin–Madison), Mark Mapstone(University of Rochester), Nicole Phillips, Yonggang Shi(University of Southern California), Melissa Petersen(University of North Texas), Michelle M. Mielke(Wake Forest University), Badri N. Vardarajan(Columbia College), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Fan Zhang(University of North Texas), Fan Zhang(University of North Texas), Leigh Johnson(University of North Texas), Justin B. Miller(Cleveland Clinic), Ozioma C. Okonkwo(University of Wisconsin–Madison), James Hall, Meredith N. Braskie(Keck Hospital of USC), R.F. Palmer, Amrita K. Cheema(Georgetown University)
Cited by 24
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
|Nature Genetics|2013|4.7k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)
|Philosophical Transactions of the Royal Society B Biological Sciences|2001|2.4k